Effect of Improved access to Antiretroviral Therapy on clinical characteristics of patients enrolled in the HIV care and treatment clinic, at Muhimbili National Hospital (MNH), Dar es Salaam, Tanzania

Mugusi, Sabina F.; Mwita, Julius C.; Francis, Joel M.; Aboud, Said; Bakari, Muhammad; Aris, Eric A.; Swai, Andrew B.; Mugusi, Ferdinand M.; Pallangyo, Kisali; Sandstrom, Eric
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p291
Academic Journal
Background: Sub-Saharan Africa has been severely affected by the HIV and AIDS pandemic. Global efforts at improving care and treatment has included scaling up use of antiretroviral therapy (ART). In Tanzania, HIV care and treatment program, including the provision of free ART started in 2004 with a pilot program at Muhimbili National Hospital in Dar es Salaam. This study describes the socio-demographic and clinical features of patients enrolled at the care and treatment clinic at MNH, Dar es Salaam, Tanzania. Methods: A cross-sectional study looking at baseline characteristics of patients enrolled at the HIV clinic at MNH between June 2004 - Dec 2005 compared to those enrolled between 2006 and September 2008. Results: Of all enrolled patients, 2408 (58.5%) were used for analysis. More females than males were attending the clinic. Their baseline median CD4 cell count was low (136 cells/μl) with 65.7% having below 200 cells/μl. Females had higher CD4 cell counts (150 cells/μl) than males (109 cells/μl) p < 0.001). The most common presenting features were skin rash and/or itching (51.6%); progressive weight loss (32.7%) and fever (23.4). Patients enrolled earlier at the clinic (2004-5) were significantly more symptomatic and had significantly lower CD4 cell count (127 cells/μl) compared to CD4 of 167 cells/μl in those seen later (2006-8) (p < 0.001). Conclusion: Patients enrolled to the MNH HIV clinic were predominantly females, and presented with advanced immune-deficiency. Improved access to HIV care and treatment services seems to be associated with patients' early presentation to the clinics in the course of HIV disease.


Related Articles

  • FACTORS INFLUENCING HAART ADHERENCE AMONG PRIVATE HEALTH CARE SECTOR PATIENTS IN A SUBURB OF THE ETHEKWINI METRO. Naidoo, Panjasaram // African Journal of Primary Health Care & Family Medicine;2009, Vol. 1 Issue 1, p28 

    Background: The advent of highly active antiretroviral therapy (HAART) ushered in a new era in the management of the AIDS pandemic with new drugs, new strategies, new vigour from treating clinicians and enthusiasm on the part of their patients. What soon became evident, however, was the vital...

  • Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Gutierrez, Absalon; Balasubramanyam, Ashok // Endocrine (1355008X);Feb2012, Vol. 41 Issue 1, p1 

    HIV-infected patients on highly active antiretroviral therapy (HAART) have increased prevalence of a number of chronic metabolic disorders of multifactorial but unclear etiology. These include disorders of lipid metabolism with or without lipodystrophy, insulin resistance, and an increased...

  • Penetration and Effectiveness of Antiretroviral Therapy in the Central Nervous System. Letendre, Scott; Ellis, Ronald J.; Best, Brookie; Bhatt, Archana; Marquie-Beck, Jennifer; LeBlanc, Shannon; Rossi, Steven; Capparelli, Edmund; McCutchan, J. Allen // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Jun2009, Vol. 8 Issue 2, p169 

    Combination antiretroviral therapy (ART) has markedly reduced morbidity and mortality among HIV-infected individuals but not the prevalence of HIV-associated neurocognitive disorders (HAND). Several conditions may be responsible for the high prevalence of cognitive impairment, including...

  • The future of antiretroviral therapy: challenges and needs. Moreno, Santiago; López Aldeguer, Jose; Arribas, José Ramón; Domingo, Pere; Iribarren, Jose Antonio; Ribera, Esteban; Rivero, Antonio; Pulido, Federico // Journal of Antimicrobial Chemotherapy (JAC);May2010, Vol. 65 Issue 5, p827 

    The introduction of combination antiretroviral therapy (cART) has substantially modified the natural history of HIV infection. At the beginning of the cART era the objective was focused on HIV-1-associated mortality and morbidity, but as this objective was accomplished other issues emerged,...

  • An Investigation of the Determinants of Adherence to Highly Active Anti-Retroviral Therapy (HAART) in Aboriginal Men in the Downtown Eastside (DTES) of Vancouver. Chongo, Meck; Lavoie, Josée G.; Hoffman, Ross; Shubair, Mamdouh // Canadian Journal of Aboriginal Community-Based HIV/AIDS Research;Winter2011, Vol. 4, p32 

    The eradication of HIV is not yet possible; therefore persons undergoing treatment must take highly active antiretroviral therapy (HAART) regularly. In British Columbia (BC), antiretrovirals are distributed at no cost but the HIV-related annual mortality rate stands at 9% (Vancouver Native Heath...

  • Longer Use of Combination Antiretroviral Therapy Associated with Reduced Risk of Cervical HPV. London, S. // International Perspectives on Sexual & Reproductive Health;Mar2015, Vol. 41 Issue 1, p55 

    The article discusses a study which showed that women infected with HIV may have a lower risk of testing positive for cervical human papillomavirus (HPV) if they were taking a combination antiretroviral therapy (cART). Topics discussed include the use of bivariate analyses to compare baseline...

  • Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis? van der Kop, Mia L. // Journal of Neurology, Neurosurgery & Psychiatry;Jan2015, Vol. 86 Issue 1, p3 

    The article presents a case study that examines the association of HIV and its treatment with antiretroviral therapy (ART) on multiple sclerosis (MS). Topics discussed include use of data of HIV patients between 1999 and 2011 followed up with records of MS, authors of the study showing that the...

  • Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. Hocqueloux, Laurent; Avettand-Fènoël, Véronique; Jacquot, Sophie; Prazuck, Thierry; Legac, Eric; Mélard, Adeline; Niang, Mohamadou; Mille, Catherine; Le Moal, Gwenaël; Viard, Jean-Paul; Rouzioux, Christine // Journal of Antimicrobial Chemotherapy (JAC);May2013, Vol. 68 Issue 5, p1169 

    Objectives To characterize viro-immunological outcomes following long-term combined antiretroviral therapy (cART) initiated during primary HIV infection (PHI) or chronic HIV infection (CHI) and to identify factors predictive of optimal viro-immunological responder (OVIR) status. Methods This was...

  • The Influence of ART on the Treatment of Trichomonas vaginalis Among HIV-Infected Women. Adamski, Alys; Clark, Rebecca A.; Mena, Leandro; Henderson, Harold; Levison, Judy; Schmidt, Norine; Gebrekristos, Hirut T.; Martin, David H.; Kissinger, Patricia // Clinical Infectious Diseases;Sep2014, Vol. 59 Issue 6, p883 

    Women coinfected with human immunodeficiency virus (HIV) and Trichomonas vaginalis and who are treated with 2 grams metronidazole (MTZ) are more likely to have persistent infections if they are receiving antiretroviral therapy compared with similar women treated with multidose MTZ.Objective....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics